Every time our body encounters a new disease-causing agent, a crucial defense system called adaptive immunity comes into play ...
Seismic Therapeutic Inc. has provided preclinical data for S-4321, a novel dual-cell bidirectional (DcB) PD-1:FcγRIIb antibody being developed for the treatment of autoimmune disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results